Notes
Bull. Korean Chem. Soc. 2011, Vol. 32, No. 11 4069
(R)-α-(3,4-Dihydro-2(1H)-isoquinolinyl)phenylacetic
diamine, subsequent spontaneous cyclization can provide a
convenient procedure for asymmetric syntheses of 3-sub-
stituted morpholin-2-ones and piperazin-2-ones. The simple
protocol with mild condition and the spontaneous removal
of chiral auxiliary suggests further applications to asym-
metric syntheses of various heterocyclic compounds.
1
Acid L-diisopropyl Malate Ester (6). H NMR (CDCl3,
400 MHz, major diastereomer) 7.52-7.08 (m, 9H), 5.45 (m,
1H), 5.08 (m, 1H), 4.84 (m, 1H), 4.35 (s, 1H), 3.72 (m, 1H),
2.88-2.78 (m, 6H), 1.28-1.06 (m, 12H); 13C NMR (CDCl3,
100 MHz, major diastereomer) 170.7, 168.4, 168.2, 134.3,
128.9, 128.7, 128.6, 128.5, 126.7, 126.1, 125.6, 72.9, 69.7,
69.1, 68.8, 53.6, 48.2, 36.5, 28.9, 21.7, 21.6.
Experimental
(R)-α-(Benzylamino)phenylacetic Acid L-diisopropyl
1
General Procedure for the Asymmetric Nucleophilic
Substitution via Dynamic Kinetic Resolution. To a solu-
tion of α-bromo ester (1 and 9) in CH2Cl2 (ca. 0.1 M) at
room temperature were added DIEA (1.0 equiv), TBAI (1.0
equiv) and an amine nucleophile (1.5 equiv). After the
resulting reaction mixture was stirred at room temperature
for 12-48 h, the solvent was evaporated and the crude
material was purified by column chromatography to give a
α-amino ester. The drs of 2 and 4-8 were determined by 1H
NMR integration of hydrogens of two diastereomers and the
ers of 10-18 were determined by chiral stationary phase
HPLC.
Malate Ester (7). H NMR (CDCl3, 400 MHz, major
diastereomer) 7.40-7.26 (m, 10H), 5.45 (m, 1H), 5.08 (m,
1H), 4.84 (m, 1H), 4.51 (s, 1H), 3.81 (m, 2H), 2.76 (m, 2H),
1.25 (d, J = 6.4 Hz, 3H), 1.22 (d, J = 6.4 Hz, 3H), 1.10 (d, J
= 6.4 Hz, 3H), 1.05 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3,
100 MHz, major diastereomer) 171.9, 168.5, 168.1, 139.0,
137.2, 128.7, 128.6, 128.2, 127.8, 127.7, 127.3, 69.8, 69.4,
68.8, 63.9, 51.3, 36.4, 21.7, 21.6.
(R)-α-(Phenethylamino)phenylacetic Acid L-diisopropyl
1
Malate Ester (8). H NMR (CDCl3, 400 MHz, major
diastereomer) 7.35-7.19 (m, 10H), 5.41 (m, 1H), 5.05 (m,
1H), 4.82 (m, 1H), 4.49 (s, 1H), 2.85-2.73 (m, 6H), 1.92 (br,
1H), 1.25-1.02 (m, 12H); 13C NMR (CDCl3, 100 MHz, major
diastereomer) 172.1, 168.5, 167.9, 139.7, 137.6, 128.6,
128.4, 128.1, 127.6, 126.2, 69.8, 69.2, 68.7, 65.2, 49.1, 36.4,
21.7, 21.5.
(R)-α-(Dibenzylamino)phenylacetic Acid L-diisopropyl
1
Malate Ester (2b). H NMR (CDCl3, 400 MHz, major
diastereomer) 7.39-7.20 (m, 15H), 5.60 (m, 1H), 5.17 (m,
1H), 4.95 (m, 1H), 4.71 (s, 1H), 3.80 (s, 4H), 2.85 (m, 2H),
1.32 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 6.4 Hz, 3H), 1.15 (d, J
= 6.0 Hz, 3H), 1.10 (d, J = 6.0 Hz, 3H); 13C NMR (CDCl3,
100 MHz, major diastereomer) 171.3, 168.6, 168.3, 139.6,
136.5, 129.0, 128.9, 128.8, 128.3, 128.2, 127.8, 127.0, 69.8,
69.0, 68.8, 65.4, 53.9, 36.6, 21.8, 21.7. Subsequent reductive
cleavage of 2b using LiAlH4 furnished (R)-2-dibenzylamino-
N-Benzyl-3-(R)-phenyl-morpholin-2-one (10). 1H NMR
(CDCl3, 400 MHz) 7.58-7.24 (m, 10H), 4.55 (dt, J = 11.0
Hz, 3.1 Hz, 1H), 4.37 (m, 1H), 4.26 (s, 1H), 3.77 (d, J = 13.4
Hz, 1H), 3.17 (d, J = 13.3 Hz, 1H), 2.99 (m, 1H), 2.64 (m,
1H). The spectral data were identical to those of the authentic
material reported previously.3b CSP-HPLC (Chiralpak AD-
H column; 10% 2-propanol in hexane; 0.5 mL/min) 90:10 er,
20.1 min (major enantiomer), 24.5 min (minor enantiomer).
N-Benzyl-3-(R)-methyl-morpholin-2-one (11). 1H NMR
(CDCl3, 400 MHz) 7.34-7.28 (m, 5H), 4.32 (m, 2H), 3.96 (d,
J = 13.4 Hz, 1H), 3.42 (q, J = 6.9 Hz, 1H), 3.33 (d, J = 13.4
Hz, 1H), 2.86 (dt, J = 12.9 Hz, 3.7 Hz, 1H), 2.52 (m, 1H),
1.56 (d, J = 6.7 Hz, 3H). The spectral data were identical to
those of the authentic material reported previously.3b CSP-
HPLC (Chiralpak AD-H column; 2% 2-propanol in hexane;
0.5 mL/min) 82:18 er, 39.8 min (major enantiomer), 45.9
min (minor enantiomer).
N-(m-Methylbenzyl)-3-(R)-phenyl-morpholin-2-one (12).
1H NMR (CDCl3, 400 MHz) 7.58-7.03 (m, 9H), 4.54 (dt, J =
11.4 Hz, 3.0 Hz, 1H), 4.34 (m, 1H), 4.24 (s, 1H), 3.73 (d, J =
13.3 Hz, 1H), 3.12 (d, J = 13.3 Hz, 1H), 2.97 (m, 1H), 2.62
(m, 1H), 2.32 (s, 3H). The spectral data were identical to
those of the authentic material reported previously.3b CSP-
HPLC (Chiralpak AD-H column; 10% 2-propanol in hexane;
0.5 mL/min) 88:12 er, 17.7 min (major enantiomer), 20.8
min (minor enantiomer).
1
2-phenylethanol 3. H NMR (CDCl3, 400 MHz) 7.44-7.25
(m, 15H), 4.14 (dd, J = 10.6, 10.6 Hz, 1H), 3.96-3.90 (m,
3H), 3.62 (m, 1H), 3.15 (d, J = 13.4 Hz, 1H), 3.01 (br, 1H).
The enantiomeric ratio of 3 was determined to be 88:12 in
favor of the R enantiomer by CSP-HPLC using racemic
material as a standard. (Chiralcel OD column; 10% 2-pro-
panol in hexane; 0.5 mL/min): 12.7 min (R), 19.4 min (S).
(R)-α-(N-Benzyl phenethylamino)phenylacetic Acid L-
diisopropyl Malate Ester (4). 1H NMR (CDCl3, 400 MHz,
major diastereomer) 7.34-6.97 (m, 15H), 5.57 (m, 1H), 5.11
(m, 1H), 4.92 (m, 1H), 4.77 (s, 1H), 3.91 (d, J = 14.4 Hz,
1H), 3.80 (d, J = 14.4 Hz, 1H), 2.92-2.80 (m, 6H), 1.27 (d, J
= 6.4 Hz, 3H), 1.24 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 6.4 Hz,
3H), 1.10 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz,
major diastereomer) 171.4, 168.6, 168.3, 140.2, 139.8,
136.7, 128.9, 128.8, 128.7, 128.3, 128.2, 127.8, 126.9,
125.8, 69.8, 69.0, 68.8, 67.2, 55.1, 51.8, 36.6, 34.6, 21.8,
21.7.
(R)-α-(1-Pyrrolidinyl)phenylacetic Acid L-diisopropyl
1
Malate Ester (5). H NMR (CDCl3, 400 MHz, major
diastereomer) 7.48-7.27 (m, 5H), 5.41 (m, 1H), 5.03 (m, 1H),
4.85 (m, 1H), 4.02 (s, 1H), 2.79-2.46 (m, 6H), 1.79 (m, 4H),
1.29-1.03 (m, 12H); 13C NMR (CDCl3, 100 MHz, major
diastereomer) 170.8, 168.3, 168.2, 137.1, 128.6, 128.5,
128.3, 73.3, 69.6, 68.7, 67.4, 61.1, 52.4, 49.7, 36.5, 23.7,
23.4, 21.8, 21.4.
N-(p-Methoxybenzyl)-3-(R)-phenyl-morpholin-2-one
1
(13). H NMR (CDCl3, 400 MHz) 7.58-7.31 (m, 5H), 7.16
(d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.54 (dt, J =
11.0 Hz, 3.0 Hz, 1H), 4.37 (m, 1H), 4.24 (s, 1H), 3.79 (s,
3H), 3.71 (d, J = 13.2 Hz, 1H), 3.12 (d, J = 13.2 Hz, 1H),
2.99 (m, 1H), 2.64 (m, 1H). The spectral data were identical